
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6055775
[patent_doc_number] => 20110112135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Imidazo [1,2-A] Pyridine Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/809893
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44933
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112135.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809893 | Imidazo [1,2-A] Pyridine Compounds | Dec 18, 2008 | Abandoned |
Array
(
[id] => 5586046
[patent_doc_number] => 20090105248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => '3-MONOSUBSTITUTED TROPANE DERIVATIVES AS NOCICEPTIN RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/338384
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14184
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105248.pdf
[firstpage_image] =>[orig_patent_app_number] => 12338384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/338384 | 3-monosubstituted tropane derivatives as nociceptin receptor ligands | Dec 17, 2008 | Issued |
Array
(
[id] => 6617705
[patent_doc_number] => 20100324036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/809824
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17493
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809824
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809824 | SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR ANTAGONISTS | Dec 17, 2008 | Abandoned |
Array
(
[id] => 6448222
[patent_doc_number] => 20100280063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => '8-ANILINOIMIDAZOPYRIDINES AND THEIR USE AS ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/808346
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25061
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280063.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808346
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808346 | 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents | Dec 17, 2008 | Issued |
Array
(
[id] => 123075
[patent_doc_number] => 07704989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics'
[patent_app_type] => utility
[patent_app_number] => 12/337007
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17060
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704989.pdf
[firstpage_image] =>[orig_patent_app_number] => 12337007
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/337007 | Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics | Dec 16, 2008 | Issued |
Array
(
[id] => 6498872
[patent_doc_number] => 20100286189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => '(AZA)INDOLE DERIVATIVE SUBSTITUTED IN POSITION 5, PHARMACEUTICAL COMPOSITION COMPRISING IT, INTERMEDIATE COMPOUNDS AND PREPARATION PROCESS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/745356
[patent_app_country] => US
[patent_app_date] => 2008-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18306
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286189.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745356 | (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor | Dec 15, 2008 | Issued |
Array
(
[id] => 5285493
[patent_doc_number] => 20090099168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'HIV Integrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/316027
[patent_app_country] => US
[patent_app_date] => 2008-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30416
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099168.pdf
[firstpage_image] =>[orig_patent_app_number] => 12316027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/316027 | HIV Integrase inhibitors | Dec 8, 2008 | Abandoned |
Array
(
[id] => 4469790
[patent_doc_number] => 07943559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Cyclopropanated macrocyclic ketones and lactones'
[patent_app_type] => utility
[patent_app_number] => 12/329091
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4560
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12329091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/329091 | Cyclopropanated macrocyclic ketones and lactones | Dec 4, 2008 | Issued |
Array
(
[id] => 4469791
[patent_doc_number] => 07943560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Cyclopropanated macrocyclic ketones and lactones'
[patent_app_type] => utility
[patent_app_number] => 12/329112
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4530
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12329112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/329112 | Cyclopropanated macrocyclic ketones and lactones | Dec 4, 2008 | Issued |
Array
(
[id] => 7795910
[patent_doc_number] => 08124616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Bicyclic PPAT inhibitors as antibacterial agents'
[patent_app_type] => utility
[patent_app_number] => 12/324347
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9423
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12324347
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/324347 | Bicyclic PPAT inhibitors as antibacterial agents | Nov 25, 2008 | Issued |
Array
(
[id] => 5534337
[patent_doc_number] => 20090234125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Amorphous retapamulin and processes for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/313962
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2774
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234125.pdf
[firstpage_image] =>[orig_patent_app_number] => 12313962
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313962 | Amorphous retapamulin and processes for preparation thereof | Nov 25, 2008 | Abandoned |
Array
(
[id] => 8932702
[patent_doc_number] => 08492402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester'
[patent_app_type] => utility
[patent_app_number] => 12/744493
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5747
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12744493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744493 | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester | Nov 25, 2008 | Issued |
Array
(
[id] => 5539790
[patent_doc_number] => 20090221595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Crystalline form of sitagliptin'
[patent_app_type] => utility
[patent_app_number] => 12/313975
[patent_app_country] => US
[patent_app_date] => 2008-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5019
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221595.pdf
[firstpage_image] =>[orig_patent_app_number] => 12313975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313975 | Crystalline form of sitagliptin | Nov 24, 2008 | Abandoned |
Array
(
[id] => 6149902
[patent_doc_number] => 20110021497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'AMINO TRIAZOLES AS PI3K INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/744940
[patent_app_country] => US
[patent_app_date] => 2008-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30214
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744940
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744940 | Amino triazoles as PI3K inhibitors | Nov 20, 2008 | Issued |
Array
(
[id] => 5265547
[patent_doc_number] => 20090118232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/273039
[patent_app_country] => US
[patent_app_date] => 2008-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43903
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12273039
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/273039 | Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof | Nov 17, 2008 | Issued |
Array
(
[id] => 4644452
[patent_doc_number] => 08022057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'MAPK/ERK kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/267353
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38232
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12267353
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/267353 | MAPK/ERK kinase inhibitors | Nov 6, 2008 | Issued |
Array
(
[id] => 7545479
[patent_doc_number] => 08053451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Hydroxybenzoate salts of metanicotine compounds'
[patent_app_type] => utility
[patent_app_number] => 12/264288
[patent_app_country] => US
[patent_app_date] => 2008-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15585
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053451.pdf
[firstpage_image] =>[orig_patent_app_number] => 12264288
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/264288 | Hydroxybenzoate salts of metanicotine compounds | Nov 3, 2008 | Issued |
Array
(
[id] => 8164661
[patent_doc_number] => 08173635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/262459
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62981
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262459 | Kinase inhibitors | Oct 30, 2008 | Issued |
Array
(
[id] => 6352858
[patent_doc_number] => 20100249419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'UTILIZATION OF NOVEL COMPOUNDS WITH AMYLOID AFFINITY AND METHOD OF PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/740658
[patent_app_country] => US
[patent_app_date] => 2008-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20951
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740658 | UTILIZATION OF NOVEL COMPOUNDS WITH AMYLOID AFFINITY AND METHOD OF PRODUCING THE SAME | Oct 27, 2008 | Abandoned |
Array
(
[id] => 6518942
[patent_doc_number] => 20100216994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/740646
[patent_app_country] => US
[patent_app_date] => 2008-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15823
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216994.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740646 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | Oct 27, 2008 | Abandoned |